Image may be NSFW.
Clik here to view.
Clik here to view.
Ofev and Esbriet, First Drugs Approved for Idiopathic Pulmonary Fibrosis
The FDA recently approved Ofev (nintedanib) and Esbriet (pirfenidone), two "first-in-class" agents for the treatment of idiopathic pulmonary fibrosis (IPF). Both drugs have been shown to slow...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Long-term Antiplatelet Therapy FDA Medwatch Safety Alert
The FDA is reviewing preliminary data from the Dual Antiplatelet Therapy (DAPT) study, which showed that long-term antiplatelet therapy following drug-eluding coronary stent implantation reduced MI and...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Erratum
The OxyContin and generic oxycodone monographs have been updated to correct the dosing for patients with hepatic impairment. The start dose should be decreased by 50-66% and titrated slowly in these...
View Article
More Pages to Explore .....
